Vibegron 50 mg Once Daily Improves OABSS, OAB-q SF Score in OAB Patients ≥80 Years Old in Real-World Clinical Settings and Switching from Other OAB Drugs May Reduce Residual Urine Volume

Vibegron 50 mg Once Daily Improves OABSS, OAB-q SF Score in OAB Patients ≥80 Years Old in Real-World Clinical Settings and Switching from Other OAB Drugs May Reduce Residual Urine Volume

Takahira Kuno,1,2 Kenji Tamura,1,3 Nobutaka Shimizu,1 Hideo Fukuhara,1 Satoshi Fukata,1 Shingo Ashida,1 Takashi Karashima,1 Hirofumi Satake,3 Kohji Sawada,4 Ichiro Yamasaki,5 Fumito Komatsu,2 Hajime Kuroiwa,6 Motoaki Saito,7 Keiji Inoue1 1Department of Urology, Kochi Medical School, Kochi University...

Full description

Bibliographic Details
Main Authors: Kuno T, Tamura K, Shimizu N, Fukuhara H, Fukata S, Ashida S, Karashima T, Satake H, Sawada K, Yamasaki I, Komatsu F, Kuroiwa H, Saito M, Inoue K
Format: Article
Language:English
Published: Dove Medical Press 2023-05-01
Series:Research and Reports in Urology
Subjects:
selective 3-adrenoreceptor agonist
overactive bladder
residual urine volume
vibegron
mirabegron
Online Access:https://www.dovepress.com/vibegron-50-mg-once-daily-improves-oabss-oab-q-sf-score-in-oab-patient-peer-reviewed-fulltext-article-RRU

Internet

https://www.dovepress.com/vibegron-50-mg-once-daily-improves-oabss-oab-q-sf-score-in-oab-patient-peer-reviewed-fulltext-article-RRU

Similar Items